HIGHLIGHTS
- who: Maru00eda Torrente from the Agostino Gemelli University Polyclinic (IRCCS), Italy have published the paper: Assessing the risk of cardiovascular events in patients receiving immune checkpoint inhibitors, in the Journal: (JOURNAL)
- what: This study provides real-world observational data on the risk of CE associated with ICI treatment, which can extend beyond myocarditis.
- how: The authors conducted a single-institution retrospective study at the Puerta de Hierro-Majadahonda University Hospital in Madrid Spain. Risk factors with a P-value lower than 0.05 in the univariable analysis were developed into multivariable models. The . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.